Kimmtrak Tebentafusp Sales Increase By 64% In 2023

In the battle against melanoma, Kimmtrak has emerged as a groundbreaking treatment that offers an innovative approach of treatment with significant commercial potential. Although Kimmtrak is currently only approved for the treatment of uveal melanoma, clinical trials are being conducted to…#tebentafusp #immunocore
Source: Reuters: Health - Category: Consumer Health News Source Type: news